Call For More Information (410) Skype715-2111
Blog: Recent Posts
  1. ACOG Opinion on Noninvasive Prenatal Genetic Testing

    Noninvasive Prenatal Testing for Fetal Aneuploidy ABSTRACT: Noninvasive prenatal testing that uses cell free fetal DNA from the plasma of pregnant women offers tremendous potential as a screening tool for fetal aneuploidy. Cell free fetal DNA testing should be an informed patient choice after pretest counseling and should not be...
  2. Choosing to Participate in Prenatal Screening for Down Syndrome

    New prenatal screening test for Down syndrome raises questions LEISA SCOTT IT RAINED the day they got the news. Big, pelting drops, as if some screenwriter well-versed in melodrama was dictating the scene. Annie Love couldn’t take the call. She’d been going “slowly nuts” waiting for diagnosis day to arrive...

Prenatal Genetic Testing

Ravgen was founded with the goal of developing fetal DNA sequencing methods for patients seeking a prenatal test which is both safe during pregnancy and highly accurate. The key to developing this technology lies in Ravgen’s ability to increase the percentage of fetal DNA present in blood from the pregnant mother. Increasing the percentage of fetal DNA in a tube of blood from the mother is the first step towards the development of noninvasive prenatal diagnostic testing for many genetic disorders such as Downs syndrome. Current applications for noninvasive prenatal testing include single gene disorders such as cystic fibrosis, sickle cell anemia, the Eastern European Jewish panel, and paternity testing.

Please visit the specific page for each noninvasive prenatal test to learn more about our research and testing. Ravgen welcomes inquiries regarding prenatal tests which are not seen here as our laboratory is continuously moving forward in this field.